TD Cowen Downgrades Jasper Therapeutics to Hold

Benzinga Newsdesk www.benzinga.com Negative 88.1%

Neg 88.1% Neu 0% Pos 0%

TD Cowen analyst Yaron Werber downgrades Jasper Therapeutics (NASDAQ:JSPR) from Buy to Hold.

Comments

No comments yet. Be the first!